Phase I trial investigating the tolerability of antisense PTP-1B gene therapy in obese volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Sep 2013
At a glance
- Drugs IONIS-PTP1BRx (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions
- 25 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 07 Dec 2012 Positive results were reported in an Isis Pharmaceuticals media release.
- 07 Dec 2012 Status changed from recruiting to completed.